Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04675775 · ClinicalTrials.gov registry record · NA
The BRAINFOOD Trial to Prevent Recurrent Hepatic Encephalopathy.
A NA study, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 17
- Enrollment target
NCT04675775: Completed NA study, sponsored by University of Michigan.
NCT04675775 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 17 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04675775, a NA study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 17 participants
- Enrollment target
Study Summary
This study is being completed for patients with cirrhosis, including patients with a prior history of hepatic encephalopathy (HE) to evaluate the feasibility and benefits of medically-tailored meals as an intervention. Patients will be enrolled from the University of Michigan and will complete the baseline assessments in-person or remotely. In addition participants will complete study related materials before, during and after treatment with medically-tailored meals (MTM). After completing the study meals, participants will return for follow-up or have this visit completed remotely as well as have an observational period for 12 more weeks.
Primary Outcome
Overall participant retention rate based on proportion of participants who completed all study visits
Interventions
- OTHER Medically-tailored meals (MTM)
- DIETARY_SUPPLEMENT Protein supplements
- BEHAVIORAL Nutrition education handout
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2021-01-21 |
| Est. Completion | 2023-03-05 |
| Phase | NA |
What the finished NCT04675775 record still lists
NCT04675775 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 17 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 3 interventions - of which Medically-tailored meals (MTM) is the first listed.
NCT04675775 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04675775 about?
NCT04675775 is a clinical study titled "The BRAINFOOD Trial to Prevent Recurrent Hepatic Encephalopathy.". This study is being completed for patients with cirrhosis, including patients with a prior history of hepatic encephalopathy (HE) to evaluate the feasibility and benefits of medically-tailored meals as an intervention. Patients will be enrolled from the University of Michigan and will complete the ...
What is the current status of trial NCT04675775?
This trial is currently completed. It is a NA study. The enrollment target is 17 participants. The study started on 2021-01-21. Estimated completion is 2023-03-05.
What interventions are being tested in trial NCT04675775?
The interventions under investigation include: Medically-tailored meals (MTM) (OTHER), Protein supplements (DIETARY_SUPPLEMENT), Nutrition education handout (BEHAVIORAL).
Who is sponsoring clinical trial NCT04675775?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04675775's enrollment target sits among peer trials
17 1871st of 2000 higher than 130 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02090140 · 17 participants · NA
Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects
- NCT03317860 · 17 participants · NA
Improving Measurement and Treatment of Post-stroke Neglect
- NCT04356469 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children
- NCT04414046 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI